AIP
RGNX icon

Almanack Investment Partners’s Regenxbio RGNX Stock Holding History

Almanack Investment Partners’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$167K Buy
+13,955
New +$116K 0.02% 303

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Almanack Investment Partners's RGNX Position: Q2 2026 in Review

Almanack Investment Partners opened a new position in Regenxbio (RGNX) in Q2 2026: 13,955 shares worth $167K. The stake represents 0.02% of the portfolio and ranks #303 among its holdings.

52 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Almanack Investment Partners held 13,955 shares of Regenxbio worth $167K as of Q2 2026.
  • Regenxbio was a new Almanack Investment Partners position in Q2 2026.
  • Regenxbio made up 0.02% of Almanack Investment Partners's portfolio in Q2 2026, its #303 holding.
  • 52 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Almanack Investment Partners's 13F filing for Q2 2026, filed 30 Jul 2026.